Baldwin, Vance Bipartisan Bill to Ensure Taxpayer-Funded Inventions Are Made in America Passes Senate
Invent Here, Make Here Act expands Baldwin-championed requirements to manufacture cutting-edge technologies in the U.S.
WASHINGTON, D.C. – Today, U.S. Senator Tammy Baldwin (D-WI) announced her bipartisan legislation with Senator J.D. Vance (R-OH), the Invent Here, Make Here Act of 2023, passed unanimously on the Senate floor. The bipartisan legislation ensures taxpayer-funded inventions are not manufactured in adversarial countries like China, but rather, in the United States. The bill builds on bipartisan legislation championed by Senator Baldwin and signed into law that requires taxpayer-funded research that leads to inventions that boost national security are made in the United States.
While current law requires federally funded inventions to be manufactured in the United States, the requirement is often waived, allowing cutting-edge, taxpayer-funded technologies to be licensed to foreign companies and manufactured in countries like China. In a noteworthy example of the flawed process, an investigative report in August 2022 found that a breakthrough battery technology invented in a federal lab had been licensed to a Chinese company and was being manufactured in China.
The Invent Here, Make Here Act would prohibit waivers for applications that intend to manufacture in a “country of concern” – currently China, Russia, North Korea, and Iran. The legislation would also increase scrutiny of waiver requests, requiring written authorization by the President of the United States.
The bipartisan legislation will also help American companies access and manufacture inventions developed with taxpayer-funded research. The bill requires the National Institute of Standards and Technology to improve coordination with other federal agencies to encourage the commercialization of federal research by domestic manufacturers and ensure that projects funded through the Technology, Innovation, and Partnerships Directorate at the National Science Foundation prioritize domestic manufacturing.
In the 2023 National Defense Authorization Act (NDAA), Senators Baldwin and Rob Portman (R-OH) included a provision to strengthen the waiver process for inventions resulting from federal research at the Department of Homeland Security. These new rules added an additional layer of review for all waivers and prohibited waivers for companies that will manufacture in hostile countries.
An online version of this release is available here.
NOTE: This press release was submitted to Urban Milwaukee and was not written by an Urban Milwaukee writer. While it is believed to be reliable, Urban Milwaukee does not guarantee its accuracy or completeness.
Mentioned in This Press Release
Recent Press Releases by U.S. Sen. Tammy Baldwin
Baldwin’s Bill to Connect Veterans with Earned Benefits Now Heads to the President’s Desk
Dec 19th, 2024 by U.S. Sen. Tammy BaldwinClick here to hear from Veterans how County Veteran Service Officers connect them with benefits
Baldwin Celebrates AstraZeneca’s Commitment to Extend $35 Cap to New Inhalers
Dec 13th, 2024 by U.S. Sen. Tammy BaldwinAction is the latest following Baldwin’s investigation into the extremely high prices these companies charge for inhalers